CGFNS International Joins WHO Stakeholder Network to Advance Rehabilitation Care CGFNS International Jul 23, 2024 22:00 HKT/SGT Read More
Sirnaomics宣布完成针对靶向APOC3用于治疗心血管疾病的STP125G 在非人灵长类动物模型中安全性和有效性的IND准备阶段研究 Sirnaomics Ltd. Jul 23, 2024 18:26 HKT/SGT Read More
Sirnaomics宣佈完成針對靶向APOC3用於治療心血管疾病的STP125G 在非人靈長類動物模型中安全性和有效性的IND準備階段研究 Sirnaomics Ltd. Jul 23, 2024 17:52 HKT/SGT Read More
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program Avance Clinical Jul 23, 2024 16:00 HKT/SGT Read More
Q&M Dental Group Advanced "Treatment Plan" AI-Module Released Today Q&M Dental Group Ltd Jul 23, 2024 10:30 HKT/SGT Read More
醫療器械是否回暖 貝康醫療(2170.HK)上半年銷售業績逆勢爆發 Suzhou Basecare Medical Corporation Limited Jul 15, 2024 08:51 HKT/SGT Read More
医疗器械是否回暖 贝康医疗(2170.HK)上半年销售业绩逆势爆发 Suzhou Basecare Medical Corporation Limited Jul 15, 2024 07:42 HKT/SGT Read More
Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy Lexaria Bioscience Jul 08, 2024 21:10 HKT/SGT Read More
Eisai Announces Move to Solo Development and Commercialization of Farletuzumab Ecteribulin (FZEC) Antibody Drug Conjugate (ADC) Eisai Jul 02, 2024 12:01 HKT/SGT Read More
CGFNS International Announces First Global Credential for Rehab Nurses CGFNS International Jun 28, 2024 06:00 HKT/SGT Read More
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801) HighTide Therapeutics Inc. Jun 21, 2024 18:30 HKT/SGT Read More
Eisai Continues Contract for FY2024 Dementia Examination Project by Tokyo Bunkyo City Eisai Jun 21, 2024 14:35 HKT/SGT Read More
FDA Accepts Eisai's Filing of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Eisai Jun 10, 2024 17:50 HKT/SGT Read More
エーザイとバイオジェン、早期アルツハイマー病治療剤「レケンビ(R)」の静注維持投与に関する生物製剤承認一部変更申請が米国FDAにより受理 Eisai Jun 10, 2024 13:00 JST Read More